3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
3
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Kidney Neoplasms
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
durvalumab
8
Bevacizumab
7
tremelimumab
4
lenvatinib
3
atezolizumab
3
Nivolumab
3
Ipilimumab
3
fludarabine
2
Magnetic Resonance Imaging
2
Hepatectomy
2
Gemcitabine
2
Cyclophosphamide
2
Cisplatin
2
trastuzumab deruxtecan
1
toripalimab
1
ropidoxuridine
1
poly ICLC
1
pembrolizumab
1
brodalumab
1
Whole Genome Sequencing
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radionuclide Imaging
1
Pluvicto
1
Platinum
1
Paclitaxel
1
Laparoscopy
1
Immunotherapy, Adoptive
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Biopsy, Large-Core Needle
×
90 days
×
Clear all
NCT05520099
2026-04-29
ELEPHAS-02
Elephas
Active not recruiting
416 enrolled